Financial Advisory Group’s Elevance Health ELV Stock Holding History

Financial Advisory Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$421K	Sell	812 -1	-0.1%	-$497	0.07%	68
2023 Q4	$383K	Hold	813	–	–	0.07%	68
2023 Q3	$354K	Sell	813 -86	-10%	-$39K	0.07%	67
2023 Q2	$399K	Hold	899	–	–	0.08%	62
2023 Q1	$413K	Buy	899 +124	+16%	+$59K	0.08%	60
2022 Q4	$398K	Sell	775 -173	-18%	-$87.8K	0.08%	62
2022 Q3	$431K	Buy	948 +1	+0.1%	+$478	0.1%	57
2022 Q2	$457K	Sell	947 -5	-0.5%	-$2.47K	0.1%	57
2022 Q1	$468K	Buy	952 +1	+0.1%	+$457	0.09%	59
2021 Q4	$441K	Hold	951	–	–	0.09%	63
2021 Q3	$355K	Hold	951	–	–	0.08%	64
2021 Q2	$363K	Buy	951 +171	+22%	+$65.3K	0.09%	65
2021 Q1	$280K	Sell	780 -170	-18%	-$54.7K	0.07%	66
2020 Q4	$305K	Buy	950 +170	+22%	+$52.2K	0.08%	62
2020 Q3	$210K	Hold	780	–	–	0.07%	72
2020 Q2	$205K	Buy	+780	New	+$208K	0.07%	67
2020 Q1	–	Sell	-800	Closed	-$242K	–	68
2019 Q4	$242K	Buy	+800	New	+$220K	0.06%	73
2019 Q3	–	Sell	-800	Closed	-$244K	–	73
2019 Q2	$244K	Hold	800	–	–	0.06%	64
2019 Q1	$230K	Sell	800 -12	-1%	-$3.47K	0.06%	62
2018 Q4	$213K	Hold	812	–	–	0.07%	64
2018 Q3	$223K	Buy	+812	New	+$211K	0.06%	62

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Financial Advisory Group's ELV Position: Q1 2024 in Review

Financial Advisory Group reduced its Elevance Health (ELV) stake by 0.12% in Q1 2024, selling an estimated $497 and leaving 812 shares worth $421K. The position accounts for 0.07% of the portfolio, ranked #68.

Financial Advisory Group first reported a position in ELV in Q3 2018 and has held it in 21 quarters since. The position peaked at $468K in Q1 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Financial Advisory Group held 812 shares of Elevance Health worth $421K as of Q1 2024.
Financial Advisory Group sold 1 Elevance Health share in Q1 2024, an estimated $497.
Elevance Health made up 0.07% of Financial Advisory Group's portfolio in Q1 2024, its #68 holding.
Financial Advisory Group first reported a position in Elevance Health in Q3 2018 and has held it in 21 quarters since.
Financial Advisory Group's Elevance Health position peaked at $468K in Q1 2022.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Financial Advisory Group's 13F filing for Q1 2024, filed 10 May 2024.